Advertisement

Topics

Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A

09:00 EDT 17 May 2011 |

Seattle-based Resolve Therapeutics raised its first $2 million to execute on a plan that challenges about 30 years of conventional wisdom of how you make money in biotech. And it took some creative thinking from a couple of New York-based venture firms to pull it together. The plan, crafted by Resolve CEO Jim Posada, is [...]

Original Article: Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A

NEXT ARTICLE

More From BioPortfolio on "Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...